A multi-national study examined the response sustainability to calcineurin inhibitors and long-term kidney survivals in children with genetic podocytopathies
Authors:
- Georgia MalakasiotiGMGeorgia Malakasioti
- Daniela IancuDIDaniela Iancu
- Chun Ting AuCAChun Ting Au
- Dongyang ZhouDZDongyang Zhou
- Anastasiia MilovanovaAMAnastasiia Milovanova
- Alexey TsyginATAlexey Tsygin
- Tomoko HorinouchiTHTomoko Horinouchi
- China NaganoCNChina Nagano
- Kandai NozuKNKandai Nozu
- Koichi KameiKKKoichi Kamei
- Shuichiro FujinagaSFShuichiro Fujinaga
- Kazumoto IijimaKIKazumoto Iijima
Open Access
- 27 July 2026
- journal article
- Published by Elsevier in Kidney International
- Vol. 110 (4) , 1022-1028
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Proteinuria Trajectory and Disease Progression in Children and Adults with IgA Nephropathy/VasculitisClinical Journal of the American Society of Nephrology, 2025
- A multicenter retrospective study of calcineurin inhibitors in nephrotic syndrome secondary to podocyte gene variantsKidney International, 2023
- Outcomes of steroid-resistant nephrotic syndrome in children not treated with intensified immunosuppressionPediatric Nephrology, 2022
- Calcineurin inhibitors in nephrotic syndrome secondary to podocyte gene mutations: a systematic reviewPediatric Nephrology, 2020
- IPNA clinical practice recommendations for the diagnosis and management of children with steroid-resistant nephrotic syndromePediatric Nephrology, 2020
- Cyclosporine A responsive congenital nephrotic syndrome with single heterozygous variants in NPHS1, NPHS2, and PLCE1Pediatric Nephrology, 2018
- Long-Term Outcome of Steroid-Resistant Nephrotic Syndrome in ChildrenJournal of the American Society of Nephrology, 2017
- Response to cyclosporine in steroid-resistant nephrotic syndrome: discontinuation is possiblePediatric Nephrology, 2015
- Partial remission with cyclosporine A in a patient with nephrotic syndrome due to NPHS2 mutationPediatric Nephrology, 2009
- Patients with Mutations in NPHS2 (Podocin) Do Not Respond to Standard Steroid Treatment of Nephrotic SyndromeJournal of the American Society of Nephrology, 2004